Advocates for HIV prevention have hailed the recent approval of a new injectable medication, lenacapavir, marketed under the brand name Yeztugo, as a significant...
WASHINGTON D.C. – In a landmark decision, the U.S. Food and Drug Administration approved a twice-yearly injection developed by Gilead Sciences to prevent HIV,...